vancomycin has been researched along with ethambutol in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Cartabuke, RH; Nguyen, HT; Nguyen, L; Ogwang, S; Singh, A; Wolff, KA | 1 |
| Aínsa, JA; Martín, C; Ramón-García, S; Thompson, CJ | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
| Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Ahmad, MN; Akunuri, R; Chopra, S; Dasgupta, A; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
| Jackson, EA; McLeod, DC | 1 |
| Adams, RM; Remington, JS; Seibert, JS; Steinberg, J | 1 |
| Hodges, GR; Snavely, SR | 1 |
| Górmiński, BM; Lisowska, K; Sedlaczek, L | 1 |
| Baek, DH; Chung, MJ; Ha, NJ; Kang, BY; Kang, JY; Kim, K; Kim, SD; Shin, EA; Yim, DS; Yun, JH | 1 |
| Gkiatas, K; Kararizos, G; Kararizou, E; Likomanos, D; Markou, I; Triantafyllou, N; Vassilopoulos, D; Zalonis, I; Zambelis, T | 1 |
| DeJesus, MA; Ehrt, S; Engelhart, CA; Healy, C; Ioerger, TR; Lin, K; Park, SW; Rücker, N; Schnappinger, D; Wang, R; Wright, MG; Xu, W | 1 |
| Boldrin, F; Espinosa, DM; Hernandez-Pando, R; Manganelli, R; Palù, G; Payan, JB; Pisu, D; Provvedi, R | 1 |
2 review(s) available for vancomycin and ethambutol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The neurotoxicity of antibacterial agents.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Cephalosporins; Chloramphenicol; Clindamycin; Colistin; Cranial Nerve Diseases; Dapsone; Erythromycin; Ethambutol; Humans; Lincomycin; Metronidazole; Nervous System Diseases; Neuromuscular Junction; Penicillins; Peripheral Nervous System Diseases; Polymyxin B; Sulfonamides; Tetracyclines; Vancomycin | 1984 |
20 other study(ies) available for vancomycin and ethambutol
| Article | Year |
|---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Western; Cyclic GMP-Dependent Protein Kinases; Drug Resistance, Microbial; Mycobacterium; Mycobacterium tuberculosis; Phagosomes; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Clofazimine; Dithiothreitol; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutathione; Hydrogen Peroxide; Membrane Transport Proteins; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rifampin; Valinomycin | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; Humans; Isoniazid; Kidney Diseases; Methenamine; Nalidixic Acid; Neomycin; Nitrofurantoin; Sulfadimethoxine; Sulfamethizole; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfisomidine; Sulfisoxazole; Vancomycin | 1974 |
Tropical fish aquariums. A source of Mycobacterium marinum infections resembling sporotrichosis.
Topics: Adult; Amphotericin B; Animals; Cycloserine; Diagnosis, Differential; Ethambutol; Ethionamide; Female; Fishes; Hobbies; Humans; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Skin; Skin Diseases, Infectious; Sporotrichosis; Vancomycin | 1970 |
Effect of inhibitors of cell envelope synthesis on beta-sitosterol side chain degradation by Mycobacterium sp. NRRL MB 3683.
Topics: Biotransformation; Cell Membrane; Cell Wall; Cycloserine; Ethambutol; Glycine; Isoniazid; Mycobacterium; Norleucine; Penicillins; Peptidoglycan; Phenylalanine; Sitosterols; Vancomycin | 1994 |
Identification of Lactobacillus ruminus SPM0211 isolated from healthy Koreans and its antimicrobial activity against some pathogens.
Topics: Adult; Base Sequence; Ciprofloxacin; DNA Fingerprinting; Drug Resistance, Bacterial; Enterococcus; Ethambutol; Feces; Humans; Korea; Lactobacillus; Microbial Sensitivity Tests; Molecular Sequence Data; Probiotics; Random Amplified Polymorphic DNA Technique; Rifampin; Staphylococcus aureus; Streptomycin; Time Factors; Vancomycin | 2005 |
Paraneoplastic limbic encephalitis presenting as acute viral encephalitis.
Topics: Acute Disease; Acyclovir; Anti-Bacterial Agents; Anticonvulsants; Carcinoma, Renal Cell; Cerebrospinal Fluid; Diagnosis, Differential; Drug Therapy, Combination; Electroencephalography; Encephalitis, Viral; Enoxaparin; Ethambutol; Follow-Up Studies; Herpesvirus 1, Human; Humans; Isoniazid; Limbic Encephalitis; Limbic System; Magnetic Resonance Imaging; Male; Meningoencephalitis; Methylprednisolone; Middle Aged; Nephrectomy; Neuropsychological Tests; Paraneoplastic Syndromes, Nervous System; Phenytoin; Rifampin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2005 |
Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
Topics: Adenosine Triphosphatases; Antitubercular Agents; Bacterial Proteins; Cell Wall; Drug Resistance, Multiple, Bacterial; Ethambutol; Galactans; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Ion Pumps; Isoniazid; Ligases; Mannosyltransferases; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Peptidoglycan; Rifampin; Serine Proteases; Thienamycins; Vancomycin | 2017 |
The Alternative Sigma Factors SigE and SigB Are Involved in Tolerance and Persistence to Antitubercular Drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Tolerance; Ethambutol; Gene Expression Regulation, Bacterial; Gentamicins; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sigma Factor; Streptomycin; Vancomycin | 2017 |